Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitner, Einat B., Achdout, Hagit, Avraham, Roy, Politi, Boaz, Cherry, Lilach, Tamir, Hadas, Yahalom-Ronen, Yfat, Paran, Nir, Melamed, Sharon, Erez, Noam, Israely, Tomer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Accelerated Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904475/
https://www.ncbi.nlm.nih.gov/pubmed/33639165
http://dx.doi.org/10.1016/j.jbc.2021.100470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904475/
https://www.ncbi.nlm.nih.gov/pubmed/33639165
http://dx.doi.org/10.1016/j.jbc.2021.100470

Ejemplares similares